Article
Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8
8 Nov 2010
Abstract excerpt
BACKGROUND: Thiadiazolidinones (TDZD) are small heterocyclic compounds first described as non-ATP competitive inhibitors of glycogen synthase kinase 3β (GSK-3β). In this study, we analyzed the effects of 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8), on murine GL261 cells growth in vitro and on the growth of established intracerebral murine gliomas in vivo. METHODOLOGY/PRINCIPAL FINDINGS: Our data...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
